BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37063761)

  • 21. Risk of recurrent venous thromboembolism and bleeding in patients with interstitial lung disease: a cohort study.
    Le Mao R; Ropars T; Tromeur C; Barnier A; Hourmant B; Guegan M; Jimenez D; Leroyer C; Lacut K; Couturaud F
    J Thromb Thrombolysis; 2022 Jan; 53(1):67-73. PubMed ID: 34232453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Spirk D; Sebastian T; Barco S; Banyai M; Beer JH; Mazzolai L; Baldi T; Aujesky D; Hayoz D; Engelberger RP; Kaeslin T; Korte W; Escher R; Husmann M; Blondon M; Kucher N
    Thromb Haemost; 2021 May; 121(5):641-649. PubMed ID: 33202448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism.
    Park H; Kang HR; Huang PL; Lo-Ciganic WH; DeRemer CE; Wilson D; Dietrich EA
    Clin Transl Sci; 2023 Jan; 16(1):128-139. PubMed ID: 36200137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
    Pawar A; Gagne JJ; Gopalakrishnan C; Iyer G; Tesfaye H; Brill G; Chin K; Bykov K
    JAMA; 2022 Mar; 327(11):1051-1060. PubMed ID: 35289881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.
    Willey VJ; Bullano MF; Hauch O; Reynolds M; Wygant G; Hoffman L; Mayzell G; Spyropoulos AC
    Clin Ther; 2004 Jul; 26(7):1149-59. PubMed ID: 15336480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics, management strategies and outcomes of patients with recurrent venous thromboembolism in the real world.
    Yamashita Y; Morimoto T; Kadota K; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Inoko M; Tada T; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sakamoto J; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T
    Sci Rep; 2022 Dec; 12(1):22437. PubMed ID: 36575292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden.
    Balabanova Y; Farahmand B; Stattin P; Garmo H; Brobert G
    BMC Urol; 2022 Feb; 22(1):15. PubMed ID: 35109829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive study.
    Lai N; Jones AE; Johnson SA; Witt DM
    J Thromb Thrombolysis; 2021 Aug; 52(2):414-418. PubMed ID: 33486650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence.
    Jiménez-Fonseca P; Gallardo E; Arranz Arija F; Blanco JM; Callejo A; Lavin DC; Costa Rivas M; Mosquera J; Rodrigo A; Sánchez Morillas R; Vares Gonzaléz M; Muñoz A; Carmona-Bayonas A
    Eur J Intern Med; 2022 Jun; 100():33-45. PubMed ID: 35227541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
    Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of parenteral anticoagulants and warfarin: impact on the risk of venous thromboembolism recurrence in the outpatient setting.
    Cai J; Preblick R; Zhang Q; Kwong WJ
    Am Health Drug Benefits; 2014 Nov; 7(8):444-51. PubMed ID: 25558306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superficial thrombophlebitis and risk for recurrent venous thromboembolism.
    Schönauer V; Kyrle PA; Weltermann A; Minar E; Bialonczyk C; Hirschl M; Quehenberger P; Schneider B; Partsch H; Eichinger S
    J Vasc Surg; 2003 Apr; 37(4):834-8. PubMed ID: 12663985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism.
    Mulder FI; Kraaijpoel N; Di Nisio M; Meyer G; Mahé I; Muñoz A; Bertoletti L; Biosca M; Maraveyas A; Büller HR; van Es N
    Thromb Res; 2019 Sep; 181():59-63. PubMed ID: 31352267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurely.
    Nieto JA; Mora D; Bikdeli B; Pérez Pinar M; Valle R; Pedrajas JM; Mahé I; González-Martínez J; Díaz-Pedroche MDC; Monreal M;
    Thromb Res; 2020 May; 189():61-68. PubMed ID: 32179295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes.
    Ageno W; Antonucci E; Poli D; Bucherini E; Chistolini A; Fregoni V; Lerede T; Pancani R; Pedrini S; Pieralli F; Pignatelli P; Pizzini AM; Podda GM; Potere N; Sarti L; Testa S; Visonà A; Palareti G;
    Res Pract Thromb Haemost; 2023 May; 7(4):100167. PubMed ID: 37229314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B; Palareti G
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.
    Tufano A; Ageno W; Di Micco P; Niglio A; Rosa V; Ballaz A; Braester A; Rubio CM; Isern V; Imbalzano E; Monreal M;
    Thromb Res; 2018 Apr; 164():69-74. PubMed ID: 29499439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.